Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study
Abstract Purpose Colorectal cancer (CRC) is one of the leading causes of cancer‐related death worldwide. Dihydroartemisinin (DHA) is an anti‐malaria agent and recent evidence indicates a broad anti‐cancer activity. Radiotherapy (RT) is the cornerstone of cancer treatment and often has synergistic ef...
Saved in:
| Main Authors: | Yuenan Wang, Xiaodong Yang, Haitao Xiao, Fada Guan, Sanjay Aneja |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Precision Radiation Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/pro6.70002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomineralized apoferritin nanoparticles delivering dihydroartemisinin and calcium for synergistic breast cancer therapy
by: Shanshan Zhao, et al.
Published: (2024-11-01) -
Effectiveness of dihydroartemisinin-piperaquine after 10 years as treatment for vivax malaria in Indonesia
by: Fanny Arcelia, et al.
Published: (2023-05-01) -
RETRACTED: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
by: You-Cai Yi, et al.
Published: (2021-11-01) -
Dihydroartemisinin enhances remyelination by switching microglia to the reparative phenotype
by: Li Liu, et al.
Published: (2025-08-01) -
Single-atom nanozyme-mediated dihydroartemisinin delivery for self-enhanced chemodynamic therapy and ferroptosis
by: Yuanlong Zhang, et al.
Published: (2025-10-01)